ACET 8-K 2026-11-05

Adicet Bio, Inc. (ACET) 8-K dated 2026-11-05 — accession 0001720580-26-000065.

Adicet Bio, Inc. (ACET) is a biotechnology company listed on NASDAQ.

Adicet Bio, Inc. filed a 8-K on 2026-11-05. Accession 0001720580-26-000065.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported ACET revenue for 2025-12-31 was $5.8M. Net income was -$116.8M. Revenue was down 46.1% from 2024-12-31 to 2025-12-31. ACET currently screens at market cap $75.7M.

Not investment advice. The ACET SEC hub lists recent forms. The stock page is the research view.